AI-Powered Ecological Forecasting: A Proactive Shield Against Plant Invasions
Revolutionizing Biosecurity with Predictive Intelligence In an era of unprecedented global connectivity, plant species are traveling across continents at an…
Revolutionizing Biosecurity with Predictive Intelligence In an era of unprecedented global connectivity, plant species are traveling across continents at an…
CoMind has secured over €85 million in total funding to advance its non-invasive brain monitoring technology. The London-based startup’s innovative approach uses photonics to measure critical brain parameters without drilling into the skull, potentially revolutionizing neurological care.
London-based neurological HealthTech startup CoMind has reportedly secured over €85 million in total funding according to recent reports, with its latest round bringing in €51 million to advance its revolutionary approach to brain monitoring. Sources indicate this represents one of the largest European neuro-device funding rounds this year, highlighting growing investor confidence in non-invasive medical technologies.